Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes

Innate Immunity

Volumn 18, Issue 6, 2012, Pages 825-833

  Shao, Baomei ^a   Munford, Robert S ^a,b   Kitchens, Richard ^a   Varley, Alan W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

acyloxyacyl hydrolase; endotoxin; HDL; Kupffer cell; LPS

Indexed keywords

ACYLOXYACYL HYDROLASE; BACTERIUM LIPOPOLYSACCHARIDE; FLUORESCEIN ISOTHIOCYANATE; HIGH DENSITY LIPOPROTEIN; HYDROLASE; LIPOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATABOLISM; CLEARANCE; COMPLEX FORMATION; CONTROLLED STUDY; DEACETYLATION; KUPFFER CELL; LIVER CELL; LIVER SINUSOID; MOUSE; NONHUMAN;

ACYLATION; ANIMALS; BIOLOGICAL TRANSPORT; CARBOXYLIC ESTER HYDROLASES; CELLS, CULTURED; FLUORESCEIN-5-ISOTHIOCYANATE; HEPATOCYTES; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS;

BACTERIA (MICROORGANISMS); MUS;

EID: 84870003651     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912442431     Document Type: Article

References (46)

1. Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol. 1979 ; 123: 2133-2143
2. Freudenberg MA, Freudenberg N, Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol. 1982 ; 63: 56-65
3. Ge Y, Ezzell RM, Tompkins RG, Warren HS. Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria. J Infect Dis. 1994 ; 169: 95-104
4. Ge YM, Ezzell RM, Clark BD, Loiselle PM, Amato SF, Warren HS. Relationship of tissue and cellular interleukin-1 and lipopolysaccharide after endotoxemia and bacteremia. J Infect Dis. 1997 ; 176: 1313-1321
5. Freudenberg N, Piotraschke J, Galanos C, Sorg C, Askaryar FA, Klosa B, et al. The role of macrophages in the uptake of endotoxin by the mouse liver. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992 ; 61: 343-349
6. Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, et al. A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem. 2007 ; 282: 13726-13735
7. Shao B, Kitchens RL, Munford RS, Rogers TE, Rockey DC, Varley AW. Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin. Hepatology. 2011 ; 54: 1051-1062
8. Nakao A, Taki S, Yasui M, Kimura Y, Nonami T, Harada A, et al. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology. 1994 ; 19: 1251-1256
9. Yasui M, Nakao A, Yuuki T, Harada A, Nonami T, Takagi H. Immunohistochemical detection of endotoxin in endotoxemic rats. Hepatogastroenterology. 1995 ; 42: 683-690
10. Takeuchi M, Nakashima Y, Miura Y, Nakagawa K, Uragoh K, Iwanaga S, et al. The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies. Pathol Res Pract. 1994 ; 190: 1123-1233
11. Praaning-van Dalen DP, Brouwer A, Knook DL. Clearance capacity of rat liver Kupffer, endothelial, and parenchymal cells. Gastroenterology. 1981 ; 81: 1036-1044
12. Freudenberg N, Freudenberg MA, Bandara K, Galanos C. Distribution and localization of endotoxin in the reticuloendothelial system (RES) and in the main vessels of the rat during shock. Path Res Pract. 1985 ; 179: 517-527
13. Van Oosten M, Van Amersfoort ES, Van Berkel TJ, Kuiper J. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res. 2001 ; 7: 381-384
14. Scott MJ, Billiar TR. beta 2-integrin induced p38MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of LPS by hepatocytes. J Biol Chem. 2008 ; 283: 29433-29446
15. Scott MJ, Liu S, Shapiro RA, Vodovotz Y, Billiar TR. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology. 2009 ; 49: 1695-1708
16. Kamimoto M, Rung-Ruangkijkrai T, Iwanaga T. Uptake ability of hepatic sinusoidal endothelial cells and enhancement by lipopolysaccharide. Biomed Res. 2005 ; 26: 99-107
17. Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology. 1995 ; 109: 1969-1976
18. Bikhazi AB, Jurjus AR, Kamal MT, Al Housseini AM, Saab RN, Jaroudi WA, et al. Kinetics of lipopolysaccharide clearance by Kupffer and parenchyma cells in perfused rat liver. Comp Biochem Physiol C Toxicol Pharmacol. 2001 ; 129: 339-348
19. Munford RS, Hall CL, Dietschy JM. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun. 1981 ; 34: 835-843
20. Kitchens RL, Thompson PA, Munford RS, O'Keefe GE. Acute inflammation and infection maintain circulating phspholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res. 2003 ; 44: 2339-2348
21. Tobias PS, Ulevitch RJ. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). J Immunol. 1983 ; 131: 1913-1916
22. Vesy CJ, Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. LPS binding protein and phospholipid transfer protein release lipopolysaccharides from gram negative bacterial membranes. Infect Immun. 1999 ; 68: 2410-2417
23. Munford RS, Andersen JM, Dietschy JM. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J Clin Invest. 1981 ; 68: 1503-1513
24. Cai L, Ji A, de Beer FC, Tannock LR, Van der Westhuyzen DR. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest. 2008 ; 118: 364-375
25. Harris HW, Rockey DC, Chau P. Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology. 1998 ; 27: 1341-1348
26. Cavaillon J-M, Fitting C, Haeffner-Cavaillon N, Kirsch SJ, Warren HS. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun. 1990 ; 58: 2375-2382
27. Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun. 1993 ; 61: 5140-5146
28. Vosbeck K, Tobias P, Mueller H, Allen RA, Arfors K-E, Ulevitch RJ, et al. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukocyte Biol. 1990 ; 47: 97-104
29. Munford R, Lu M, Varley A. Chapter 2: Kill the bacteria...and also their messengers?. Adv Immunol. 2009 ; 103: 29-48
30. Lu M, Varley AW, Ohta S, Hardwick J, Munford RS. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe. 2008 ; 4: 293-302
31. Lu M, Zhang M, Takashima A, Weiss J, Apicella MA, Li XH, et al. Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat Immunol. 2005 ; 6: 989-994
32. Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem. 2002 ; 35: 455-461
33. Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DKF. A physiologic function for alkaline phosphatase: Endotoxin detoxification. Lab Invest. 1997 ; 76: 319-327
34. Chen K, Malo M, Beasley-Topliffe L, Poelstra K, Millan J, Mostafa G, et al. A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Dig Dis Sci. 2011 ; 56: 1020-1027
35. Goldberg RF, Austen Jr WG, Zhang X, Munene G, Mostafa G, Biswas S, et al. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci 2008; 0712140105.
36. Galanos C, Lüderitz O, Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969 ; 9: 245-249
37. Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL. Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem. 2003 ; 278: 28367-28371
38. Kitchens RL, Wolfbauer G, Albers JJ, Munford RS. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem. 1999 ; 274: 34116-34122
39. Lu M, Zhang M, Kitchens RL, Fosmire S, Takashima A, Munford RS. Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J Exp Med. 2003 ; 197: 1745-1754
40. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008 ; 87: 1219-1223
41. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008 ; 57: 1470-1481
42. Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B. Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines. Alcohol Clin Exp Res. 2011 ; 35: 787-793
43. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 2010 ; 16: 1321-1329
44. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 ; 12: 1365-1371
45. Rensen PCN, Van Oosten M, Van de Bilt E, Van Eck M, Kuiper J, Van Berkel TJC. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest. 1997 ; 99: 2438-2445
46. Ghoshal S, Witta J, Zhong J, de , Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009 ; 50: 90-97